CHEN FENG-JING,SCHWABE ROBERT J.,CHEN Feng-Jing,SCHWABE Robert J.
申请号：
SI201030565
公开号：
SI2451438T1
申请日:
2010.07.01
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
Disclosed is a pharmaceutical composition of a hepatitis C viral protease inhibitor which is suitable for oral administration via a liquid- or semi-solid-filled capsule and methods of using this composition for inhibiting the replication of the hepatitis C virus (HCV) and for the treatment of an HCV infection. The liquid- or semi-solid pharmaceutical composition of the present invention comprises a compound of formula I, or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable lipids and hydrophilic surfactants.
